Skip to main content
Premium Trial:

Request an Annual Quote

NeuMoDx Molecular Nabs CE Mark for HIV Viral Load Assay

NEW YORK – NeuMoDx Molecular announced Monday that its PCR-based HIV viral load test received CE marking.

Results from the NeuMoDx HIV-1 assay, which detects HIV-1 RNA, are available in approximately 80 minutes. The test runs on the fully automated NeuMoDx 96/288 Molecular Systems, NeuMoDx President and COO Sundu Brahmasandra said in a statement. 

The Ann Arbor, Michigan-based firm offers other bloodborne viral tests for hepatitis B and hepatitis C viral loads. The company's analyzers integrate extraction and detection, allowing users to load patient samples continuously for high-throughput sample processing, the firm said. The analyzers also use NeuDry reagents that don't require refrigeration and have an ambient temperature shelf life of more than a year. 

In May, NeuMoDx received CE marking for its multiplex RT-PCR SARS-CoV-2 test. The test received Emergency Use Authorization from the US Food and Drug Administration in March.   

In 2018, NeuMoDx entered a partnership and milestone-based merger agreement with Qiagen, a firm that Thermo Fisher Scientific is in the process of acquiring.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.